FibriCheck

Hasselt, Belgium Founded: 2014 • Age: 12 yrs
Developer of a medical app to detect arrhythmias
Annual revenue - Latest available
Total funding $12.6M 6 rounds
Employees - Tracked headcount
Investors 5 Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About FibriCheck

FibriCheck is a company based in Hasselt (Belgium) founded in 2014 by Jo Van Der Auwera, Bieke Van Gorp, and Lars Grieten. FibriCheck has raised $12.62 million across 6 funding rounds from investors including EIT Health, European Union and LRM. FibriCheck offers products and services including FibriCheck App. FibriCheck operates in a competitive market with competitors including Element Science, Welltory, Story Health, Implicity and PaceMate, among others.

  • Headquarter Hasselt, Belgium
  • Founders Jo Van Der Auwera, Bieke Van Gorp, Lars Grieten
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $12.62 M (USD)

    in 6 rounds

  • Latest Funding Round
    $10.92 M (USD), Series B

    Feb 16, 2021

  • Investors
    EIT Health

    & 4 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of FibriCheck

FibriCheck offers a comprehensive portfolio of products and services, including FibriCheck App.

Product name locked
Category locked
Primary

App that detects heart arrhythmias using smartphone camera technology.

People of FibriCheck

Headcount 10-50
Employee Profiles 9
Employee Profiles
People
Stijn Evens
Head Of Medical Affairs
People
Bieke Van Gorp
Co-Founder and CBDO at FibriCheck
People
Sam Thwaites
VP Partnerships / Integration
People
Lars Grieten
CEO & Co-founder

Unlock access to complete

Funding Insights of FibriCheck

FibriCheck has successfully raised a total of $12.62M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $10.92 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in FibriCheck

FibriCheck has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, European Union and LRM.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
LRM is engaged in providing risk capital and smart money to businesses in Limburg.
Locked Locked Locked
Healthcare startups are accelerated and incubated through specialized programs.
Locked Locked Locked
Volta Ventures is focused on investing in B2B SaaS startups.
Locked Locked Locked
Premium access

Investor details for FibriCheck

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by FibriCheck

Investments
Premium access

Investment portfolio details for FibriCheck

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - FibriCheck

Premium access

Detailed financials for FibriCheck

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fibricheck Comparisons

FibriCheck Primary company
Description
Developer of a medical app to detect arrhythmias
Location
Hasselt, Belgium
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for FibriCheck

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of FibriCheck

FibriCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Element Science, Welltory, Story Health, Implicity and PaceMate, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
Locked Locked Locked
Online health and wellness tracking and training platform
Locked Locked Locked
AI-based practice management tool for providers
Locked Locked Locked
Cloud and AI-based remote monitoring for patient health is provided.
Locked Locked Locked
Cloud-based remote monitoring platform for cardiac health is provided.
Premium access

Detailed competitors of FibriCheck

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fibricheck

Premium access

Complete news archive for FibriCheck

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FibriCheck

FibriCheck was founded in 2014 and raised its 1st funding round 1 year after it was founded.

FibriCheck is headquartered in Hasselt, Belgium. It is registered at Hasselt, Limburg, Belgium.

Lars Grieten is the current CEO of FibriCheck. They have also founded this company.

FibriCheck is a funded company, having raised a total of $12.62M across 6 funding rounds to date.

FibriCheck was founded in 2014 in Hasselt, Belgium, within the health technology sector. An app is provided by the company to assist in identifying cardiac arrhythmias. Operations involve users placing a finger on a mobile devices camera for 60 seconds, allowing the optical sensor to capture pulse waveforms for analysis. The service targets patient monitoring in arrhythmia detection.

FibriCheck's top competitors include Welltory, Element Science and Story Health.

FibriCheck offers FibriCheck App.

FibriCheck has 5 investors. Key investors include EIT Health, European Union, LRM, Volta Ventures, and imec.istart.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available